At a glance
- Originator Boehringer Ingelheim Pharma KG
- Developer Boehringer Ingelheim; Boehringer Ingelheim Pharma KG
- Class Neuroprotectants; Nootropics
- Mechanism of Action Muscarinic M2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.